covid-19-vakcinam">
European Union (EU) commissioners will approve the agreement on Wednesday, Erik Meimer said at a press conference in Brussels. “Negotiations with the pharmaceutical industry are over,” a source told the news agency before the official statement to the news agency.
The EC has been negotiating with Pfizer and BioNTech for several months.
Following initial negotiations, the EC confirmed in September that it planned to provide up to 300 million doses of vaccine from these developers.
Pfizer and BioNTech said on Monday that their jointly developed new coronavirus vaccine had shown 90% effectiveness against Covid-19 infection in a third phase of trials.